Clinical trial
An Open Label Extension, Multi-Center, Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
NCT02090283 is registered in ClinicalTrials.gov with Scioderm, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label Extension, Multi-Center, Study to Evaluate the Safety of SD-101 Cream in Subjects With Epidermolysis Bullosa
- Lead sponsor
- Scioderm, Inc.
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- March 26, 2014
- Completion date
- September 14, 2018
- Enrollment
- 42 (actual)
- Sites
- 7
Conditions
As the registry lists them; a condition with its own page is linked.